tiprankstipranks
Advertisement
Advertisement

GKOS Stock Latest News

Glaukos receives permanent J-code for Epioxa
The FlyGlaukos receives permanent J-code for Epioxa
4d ago
GKOS
William Blair med tech analyst holds an analyst/industry conference call
PremiumThe Fly
William Blair med tech analyst holds an analyst/industry conference call
9d ago
ALC
COO
Glaukos price target raised to $135 from $125 at Citi
PremiumThe Fly
Glaukos price target raised to $135 from $125 at Citi
12d ago
GKOS
Seaport Research med technology analyst holds analyst/industry conference call
PremiumThe Fly
Seaport Research med technology analyst holds analyst/industry conference call
26d ago
GKOS
Glaukos announces commercial availability of Epioxa HD/Epioxa
PremiumThe Fly
Glaukos announces commercial availability of Epioxa HD/Epioxa
1M ago
GKOS
Glaukos management to meet with Piper Sandler
PremiumThe FlyGlaukos management to meet with Piper Sandler
1M ago
GKOS
Glaukos Highlights Interventional Ophthalmology Strategy in Investor Update
Premium
Company Announcements
Glaukos Highlights Interventional Ophthalmology Strategy in Investor Update
2M ago
8K
GKOS
Glaukos Expands Eye Care Pipeline With New GLK-321 Trial in Demodex Blepharitis
Premium
Company Announcements
Glaukos Expands Eye Care Pipeline With New GLK-321 Trial in Demodex Blepharitis
2M ago
GKOS
Glaukos Refines Glaucoma Implant Delivery With New Inserter Study
PremiumCompany Announcements
Glaukos Refines Glaucoma Implant Delivery With New Inserter Study
2M ago
GKOS
AI Adoption Raises Operational, Regulatory, and Reputational Risks for Glaukos Corp.
PremiumCompany Announcements
AI Adoption Raises Operational, Regulatory, and Reputational Risks for Glaukos Corp.
2M ago
GKOS
Glaukos Corp. Earnings Call Signals High-Growth Phase
PremiumCompany Announcements
Glaukos Corp. Earnings Call Signals High-Growth Phase
2M ago
GKOS
Glaukos price target raised to $127 from $125 at Needham
PremiumThe Fly
Glaukos price target raised to $127 from $125 at Needham
2M ago
GKOS
Glaukos (GKOS): Strong Execution, Expanding iDose Adoption, and De‑Risked Pipeline Support Buy Rating and $131 Target
PremiumRatingsGlaukos (GKOS): Strong Execution, Expanding iDose Adoption, and De‑Risked Pipeline Support Buy Rating and $131 Target
2M ago
GKOS
Glaukos: Strengthening Growth, Epioxa Momentum, and Justified Premium Valuation Support Buy Rating
Premium
Ratings
Glaukos: Strengthening Growth, Epioxa Momentum, and Justified Premium Valuation Support Buy Rating
2M ago
GKOS
Glaukos price target raised to $135 from $122 at Wells Fargo
Premium
The Fly
Glaukos price target raised to $135 from $122 at Wells Fargo
2M ago
GKOS
Closing Bell Movers: Palo Alto Networks down 8% on soft guidance
PremiumThe Fly
Closing Bell Movers: Palo Alto Networks down 8% on soft guidance
2M ago
CE
ADI
Glaukos Reports Record Q4 Sales, Reaffirms 2026 Outlook
PremiumCompany Announcements
Glaukos Reports Record Q4 Sales, Reaffirms 2026 Outlook
2M ago
8K
GKOS
Glaukos reports Q4 adjusted EPS (28c), consensus (30c)
PremiumThe Fly
Glaukos reports Q4 adjusted EPS (28c), consensus (30c)
2M ago
GKOS
Glaukos sees FY26 revenue $600M-$620M, consensus $613.35M
PremiumThe Fly
Glaukos sees FY26 revenue $600M-$620M, consensus $613.35M
2M ago
GKOS
Notable companies reporting after market close
PremiumThe FlyNotable companies reporting after market close
2M ago
TOL
CDNS
GKOS Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
GKOS Earnings this Week: How Will it Perform?
2M ago
GKOS
Glaukos assumed with an Outperform at William Blair
Premium
The Fly
Glaukos assumed with an Outperform at William Blair
3M ago
GKOS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >